Meera Ragavan
Overview
Explore the profile of Meera Ragavan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arana I, Liu R, Kushi L, Hahn E, Ragavan M
JNCI Cancer Spectr
. 2025 Jan;
PMID: 39873703
Background: Patients with cancer who report social needs have worse quality of life, lower healthcare access, and suboptimal health outcomes. However, screening for social needs does not happen systematically and...
2.
Sakthivel D, Ragavan A, Bafna S, Ragavan N, Ragavan M
Int Urogynecol J
. 2024 Dec;
36(1):173-176.
PMID: 39636466
Objective: To compare the outcomes of vesicovaginal fistula (VVF) repair using two different robotic systems. Design: This retrospective comparative study analysed the surgical outcomes of VVF repair utilizing two different...
3.
Kannan D, Ragavan A, Tiwari M, Ragavan N, Ragavan M
Cureus
. 2024 Nov;
16(10):e72356.
PMID: 39583429
Introduction: Pelvic organ prolapse (POP) is a common condition affecting over half of women above the age of 50. Sacrocolpopexy is a widely recognized surgical approach for apical prolapse, restoring...
4.
Ragavan M, Kannan D, Ragavan A, Tiwari M, Ragavan N
Cureus
. 2024 Nov;
16(10):e72213.
PMID: 39583382
Introduction: This study evaluates the safety and feasibility of the Medtronic Hugo robot-assisted surgery (RAS) system in gynecological and urogynecological procedures. Through a retrospective analysis of prospectively collected data from...
5.
Nassar A, Jayakrishnan R, Feng J, Shepherd F, Adib E, Cheung J, et al.
J Thorac Oncol
. 2024 Sep;
20(1):109-118.
PMID: 39260522
Introduction: Patients with advanced ALK-positive NSCLC typically have poor response to immunotherapy; the benefit of consolidation durvalumab in patients with unresectable stage III ALK-positive NSCLC remains unclear. Herein, we compare...
6.
Sakthivel D, Ragavan M, Bafna S, Tiwari M, Ragavan N
Cureus
. 2024 Jul;
16(6):e61684.
PMID: 38975515
Paraurethral leiomyoma is an exceptionally rare benign smooth muscle tumor adjacent to the female urethra, presenting diagnostic challenges due to nonspecific symptoms like urinary obstruction and dysuria. This case report...
7.
Kumar A, Ragavan M, Velazquez A, Zeng S, Wong M
J Geriatr Oncol
. 2024 Mar;
15(5):101746.
PMID: 38490915
No abstract available.
8.
Parikh D, Rodriguez G, Ragavan M, Kerr E, Asuncion M, Hansen J, et al.
Support Care Cancer
. 2024 Feb;
32(3):161.
PMID: 38366165
Purpose: Financial toxicity is a source of significant distress for patients with urologic cancers, yet few studies have addressed financial burden in this patient population. Methods: We developed a financial...
9.
Nassar A, Kim S, Aredo J, Feng J, Shepherd F, Xu C, et al.
J Thorac Oncol
. 2024 Jan;
19(6):928-940.
PMID: 38278303
Introduction: Durvalumab improves survival when used as consolidation therapy after chemoradiation (CRT) in patients with stage III NSCLC. The optimal consolidation therapy for patients with EGFR-mutant (EGFRmut) stage III NSCLC...
10.
Taneja R, Pandey S, Priyadarshi S, Goel A, Jain A, Sharma R, et al.
Int Urogynecol J
. 2023 Jan;
34(6):1165-1173.
PMID: 36708406
Introduction And Hypothesis: Cystoscopy has been routinely performed in patients suspected to be suffering from bladder pain syndrome/interstitial cystitis (BPS/IC) across the globe. The methodology reported by various guidelines appears...